MétaCan
Menu
Back to cohort
Record W2597064996 · doi:10.1126/scitranslmed.aaf2968

Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors

2017· article· en· W2597064996 on OpenAlexaff
Siddhartha S. Mitra, Abdullah H. Feroze, Jie Liu, Suzana Assad Kahn, Michael Zhang, Rogelio Esparza, Chase Richard, Vijay Ramaswamy, Marc Remke, Anne K. Volkmer, Stephen B. Willingham, Anitha Ponnuswami, Patricia Lovelace, Theresa A. Storm, Simone Schubert, Gregor Hütter, Cyndhavi Narayanan, Pauline Chu, Eric H. Raabe, Griffith Harsh, Michael D. Taylor, Michelle Monje, Yoon-Jae Cho, Ravindra Majeti, Jens Volkmer, Paul G. Fisher, Gerald A. Grant, Gary K. Steinberg, Hannes Vogel, Michael S. B. Edwards, Irving L. Weissman, Samuel Cheshier

Bibliographic record

VenueScience Translational Medicine · 2017
Typearticle
Languageen
FieldImmunology and Microbiology
TopicPhagocytosis and Immune Regulation
Canadian institutionsHospital for Sick Children
FundersNational Center for Advancing Translational SciencesNational Institute of Neurological Disorders and StrokeNational Cancer InstituteAlex's Lemonade Stand Foundation for Childhood CancerDeutsche ForschungsgemeinschaftMcKenna Claire FoundationSiebel Stem Cell InstituteCure Starts Now FoundationMatthew Larson Foundation for Pediatric Brain TumorsAmerican Brain Tumor AssociationVirginia and D.K. Ludwig Fund for Cancer ResearchCalifornia Institute for Regenerative MedicineSt. Baldrick's Foundation
KeywordsCD47MedicineAntibodyImmunologyBispecific antibodyCancer researchMonoclonal antibody

Abstract

fetched live from OpenAlex

Morbidity and mortality associated with pediatric malignant primary brain tumors remain high in the absence of effective therapies. Macrophage-mediated phagocytosis of tumor cells via blockade of the anti-phagocytic CD47-SIRPα interaction using anti-CD47 antibodies has shown promise in preclinical xenografts of various human malignancies. We demonstrate the effect of a humanized anti-CD47 antibody, Hu5F9-G4, on five aggressive and etiologically distinct pediatric brain tumors: group 3 medulloblastoma (primary and metastatic), atypical teratoid rhabdoid tumor, primitive neuroectodermal tumor, pediatric glioblastoma, and diffuse intrinsic pontine glioma. Hu5F9-G4 demonstrated therapeutic efficacy in vitro and in vivo in patient-derived orthotopic xenograft models. Intraventricular administration of Hu5F9-G4 further enhanced its activity against disseminated medulloblastoma leptomeningeal disease. Notably, Hu5F9-G4 showed minimal activity against normal human neural cells in vitro and in vivo, a phenomenon reiterated in an immunocompetent allograft glioma model. Thus, Hu5F9-G4 is a potentially safe and effective therapeutic agent for managing multiple pediatric central nervous system malignancies.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.002

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.044
GPT teacher head0.357
Teacher spread0.313 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations425
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueScience Translational MedicineSame topicPhagocytosis and Immune RegulationFrench-language works237,207